These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27984780)

  • 21. Carbapenemases and extended-spectrum β-lactamases producing Enterobacteriaceae isolated from Tunisian and Libyan hospitals.
    Mathlouthi N; Al-Bayssari C; El Salabi A; Bakour S; Ben Gwierif S; Zorgani AA; Jridi Y; Ben Slama K; Rolain JM; Chouchani C
    J Infect Dev Ctries; 2016 Aug; 10(7):718-27. PubMed ID: 27482803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spread of ESBL/AmpC-producing Escherichia coli and Klebsiella pneumoniae in the community through ready-to-eat sandwiches in Algeria.
    Yaici L; Haenni M; Métayer V; Saras E; Mesbah Zekar F; Ayad M; Touati A; Madec JY
    Int J Food Microbiol; 2017 Mar; 245():66-72. PubMed ID: 28135647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence, prevalence and genetic environment of CTX-M beta-lactamases in Enterobacteriaceae from Indian hospitals.
    Ensor VM; Shahid M; Evans JT; Hawkey PM
    J Antimicrob Chemother; 2006 Dec; 58(6):1260-3. PubMed ID: 17071956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTX-M-15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73, and ST405 in both community and hospital settings.
    Fam N; Leflon-Guibout V; Fouad S; Aboul-Fadl L; Marcon E; Desouky D; El-Defrawy I; Abou-Aitta A; Klena J; Nicolas-Chanoine MH
    Microb Drug Resist; 2011 Mar; 17(1):67-73. PubMed ID: 21128836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of extended spectrum beta-lactamase among clinical isolates Escherichia coli and Klebsiella pneumoniae.
    Udomsantisuk N; Nunthapisud P; Tirawatanapong T; Dansuputra M
    J Med Assoc Thai; 2011 Dec; 94(12):1504-12. PubMed ID: 22295740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of CTX-M-14- and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with bacteremia.
    Shin J; Kim DH; Ko KS
    J Infect; 2011 Jul; 63(1):39-47. PubMed ID: 21712135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands.
    Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ
    Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11.
    Denisuik AJ; Lagacé-Wiens PR; Pitout JD; Mulvey MR; Simner PJ; Tailor F; Karlowsky JA; Hoban DJ; Adam HJ; Zhanel GG;
    J Antimicrob Chemother; 2013 May; 68 Suppl 1():i57-65. PubMed ID: 23587779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Escherichia coli ST131 clonal complex (ST705) and Klebsiella pneumoniae ST15 among faecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae.
    Ríos E; López MC; Rodríguez-Avial I; Culebras E; Picazo JJ
    J Med Microbiol; 2017 Feb; 66(2):169-174. PubMed ID: 27902381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
    Zhang J; Zheng B; Zhao L; Wei Z; Ji J; Li L; Xiao Y
    BMC Infect Dis; 2014 Dec; 14():659. PubMed ID: 25466590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
    Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
    Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominance of IncL/M and IncF plasmid types among CTX-M-ESBL-producing Escherichia coli and Klebsiella pneumoniae in Bulgarian hospitals.
    Markovska R; Schneider I; Ivanova D; Mitov I; Bauernfeind A
    APMIS; 2014 Jul; 122(7):608-15. PubMed ID: 24303846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden.
    Onnberg A; Mölling P; Zimmermann J; Söderquist B
    APMIS; 2011 Apr; 119(4-5):287-95. PubMed ID: 21492229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and molecular epidemiology of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in a Tunisian University Hospital.
    Dahmen S; Bettaieb D; Mansour W; Boujaafar N; Bouallègue O; Arlet G
    Microb Drug Resist; 2010 Jun; 16(2):163-70. PubMed ID: 20438347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia.
    Severin JA; Mertaniasih NM; Kuntaman K; Lestari ES; Purwanta M; Lemmens-Den Toom N; Duerink DO; Hadi U; van Belkum A; Verbrugh HA; Goessens WH;
    J Antimicrob Chemother; 2010 Mar; 65(3):465-9. PubMed ID: 20053690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae in spring waters.
    Li S; Zhu ZC; Wang L; Zhou YF; Tang YJ; Miao ZM
    Lett Appl Microbiol; 2015 Dec; 61(6):544-8. PubMed ID: 26347372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso.
    Ouédraogo AS; Sanou S; Kissou A; Poda A; Aberkane S; Bouzinbi N; Nacro B; Ouédraogo R; Van De Perre P; Carriere C; Decré D; Jean-Pierre H; Godreuil S
    Microb Drug Resist; 2017 Jan; 23(1):63-70. PubMed ID: 27092971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae Isolates from rivers and lakes in Switzerland.
    Zurfluh K; Hächler H; Nüesch-Inderbinen M; Stephan R
    Appl Environ Microbiol; 2013 May; 79(9):3021-6. PubMed ID: 23455339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.
    Hazirolan G; Mumcuoglu I; Altan G; Özmen BB; Aksu N; Karahan ZC
    Niger J Clin Pract; 2018 Jan; 21(1):81-86. PubMed ID: 29411729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.